Newsroom

French Biotech Licenses Microbiome Therapeutic to Treat Mood Disorders

Apr 17, 2020

LNC Therapeutics announces the acquisition of an exclusive worldwide license on the first patent...

Apr 15, 2020

LNC Therapeutics Announces Successful GMP Manufacturing of Xla1 for Phase 1 Clinical Trial

Mar 12, 2020

Georges Rawadi interviewed on Europe 1 radio – World Obesity Day

Mar 4, 2020

LNC Therapeutics and the National Institute for Agricultural Research (INRA) sign research...

Dec 11, 2019

Unlocking the Microbiome: Keys to Success, by Georges Rawadi

Dec 6, 2019